Press release on ByHeart Infant Formula
Home NewsPress release on ByHeart Infant Formula

Press release on ByHeart Infant Formula

November 21, 2025| News|

Last modified: April 8, 2026

Previous:
BFDA Public Health Advisory on substandard product confirmed by the Thai Food and Drug Administration via the South East Asia Regulatory Network (SEARN)
Next:
Public Consultation on “National Vigilance Strategy for Medical Products 2025”

Comments are closed.

Close Search Window
↑